Skip to content

The impact of the Analgesic Effect of an Optimized Opioid-Free Multimodal Analgesia Protocol in Cesarean Section Patients:a randomized controlled clinical study

The impact of the Analgesic Effect of an Optimized Opioid-Free Multimodal Analgesia Protocol in Cesarean Section Patients:a randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106245
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Group C:General anesthetic regimen
Group A:Ropivacaine 75mg+Dexmedetomidine 50ug+Ketorolac 30mg+ Dethasone 5mg+Epinephrine 50ug+NS to 50ml for incision .Postoperative diclofenac sodium suppository 50mg Q12h, acetaminophen tablet 1000mg

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Emergency or elective cesarean section surgery, patients aged 18-50 years old, and received neuraxial anesthesia

Exclusion criteria

Exclusion criteria: 1. Unable to provide informed consent; 2. Unable to understand written or spoken language; 3. Severe comorbidities (such as severemonary hypertension, heart failure, etc.) 4. Contraindications to neuraxial anesthesia: low coagulation function; platelet count <80×10^9/L; pregnant women who refuse or cannot cooperate with the procedure; pregnant women with shock, hypovolemia, or other hemodynamic instability; pregnant women with severe deformities, trauma, etc., which may affect puncture; pregnant women with infection at the puncture site or bacteremia that could lead to neuraxial; pregnant women with central nervous system diseases, especially spinal cord or spinal nerve root lesions; other conditions that may lead to neuraxial bleeding or infection

Design outcomes

Primary

MeasureTime frame
Numerical Rating scale;

Secondary

MeasureTime frame
Postoperative opioid use within 72 hours;Postoperative opioid use within 30d;Time to Bowel Movement;Time to oral intake;Time to Ambulation;Post-operative Nausea and Vomiting;Length of hospitalization;Number of Participants With Readmission to the Hospital;Patient reported quality of recovery and quality of life as determined by QoR-15 score;Occurrence of severe and minor complications within 30 days postoperatively;Cost per patient;Time of recovery of abdominal sensation;Itchy skin;Postoperative dizziness, headache;

Countries

China

Contacts

Public ContactKaiyun Fang

Guizhou Provincial People's Hospital

fangkaiyun@sina.cn+86 139 8553 3277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026